POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 106 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,630,000 | +289.6% | 800,000 | +60.0% | 0.09% | +340.0% |
Q2 2023 | $675,000 | -81.5% | 500,000 | 0.0% | 0.02% | -80.4% |
Q4 2022 | $3,645,000 | -5.7% | 500,000 | 0.0% | 0.10% | -8.9% |
Q3 2022 | $3,865,000 | -47.2% | 500,000 | -53.4% | 0.11% | -51.1% |
Q2 2022 | $7,314,000 | -23.1% | 1,073,995 | -10.1% | 0.23% | +19.9% |
Q1 2022 | $9,516,000 | -28.8% | 1,193,995 | -50.0% | 0.19% | +85.4% |
Q4 2021 | $13,372,000 | +39.9% | 2,387,990 | +92.1% | 0.10% | -25.9% |
Q3 2021 | $9,557,000 | – | 1,242,879 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |